Business Context and Reporting Period
This Form 6-K filing by Tiziana Life Sciences plc (the "Company") was submitted on September 7, 2021. The report serves to furnish a Regulatory News Service (RNS) announcement regarding a Change of Registered Office.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing regarding corporate administration and does not contain financial performance data.
Material Changes
The material change disclosed is the relocation of the Company's registered office. No financial or operational changes versus prior periods are detailed in this specific filing.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document explicitly states that the attached RNS announcement is furnished but not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Key Facts for Investor Verification
- The Company announced a Change of Registered Office on September 7, 2021.
- The filing is a Form 6-K submitted by a Foreign Private Issuer.
- The Chief Executive Officer, Kunwar Shailubhai, signed the report on behalf of the registrant.
- No financial results or operational metrics are included in this specific document.